UNIVERSITY OF UTAH RESEARCHERS DEVELOP FASTER, MORE ACCURATE TEST FOR LIVER CANCER THAT CAN BE ADMINISTERED ANYWHERE
It’s estimated that about 788,000 people worldwide died of liver cancer in 2015, the second-leading cause of cancer deaths, according to the latest statistics from the World Health Organization. One of the major challenges in combatting this disease is detecting it early because symptoms often don’t appear until later stages.
But a team of researchers led by University of Utah chemical engineering and chemistry professor Marc Porter and U surgeon and professor Courtney Scaife has developed a rapid portable screening test for liver cancer (hepatocellular carcinoma) that doesn’t involve sending a specimen to a blood lab and cuts the wait time for results from two weeks to two minutes. This new and inexpensive test — the team is working to lower the cost to about $3 per test — can be administered wherever the patient is, which will be particularly valuable in developing nations with little access to hospitals.
The test uses a small domino-sized plastic cartridge containing a paper membrane that selectively traps biomarkers (proteins specific to a certain disease) from biological fluids. A small droplet of blood, saliva, or urine, or even a teardrop, from the patient is dropped onto the membrane. This is followed by the droplet of gold nanoparticles, which tags the biomarkers trapped in the membrane. If the biomarkers are present, a red spot appears, signaling the patient has the disease and should seek more testing and possible treatment.
“The concept is similar to a home pregnancy test, but instead of flowing laterally, it flows through the membrane,” says Granger, the lead author on the paper.
A handheld spectrometer manufactured by project collaborator B&W Tek, a Delaware-based manufacturer of mobile spectrometers, can analyze the membranes and measure how much of the biomarkers is present, which in the future could determine the severity of the disease or how a patient is responding to treatment.
The idea for the test is a spinoff of a similar test Porter developed eight years ago that astronauts on the International Space Station used to test the cleanliness of their drinking water. “This is a smarter offshoot of that,” says Porter, who also is the director of the Nano Institute of Utah.
Now that the team has proven the concept with liver cancer and built a prototype test kit, researchers plan to evaluate the technology in Mongolia in spring of 2019. The East Asian country has the highest rate of liver cancer in the world.
The project was funded by grants from the National Institutes of Health, the National Cancer Institute through the Affordable Cancer Technologies Program and the Huntsman Cancer Institute. The team also received funding from Utah-based nutritional supplement company USANA which is interested in using a form of the test for customers with certain vitamin deficiencies.
“USANA has a keen interest in the ability to measure certain vitamins and biomarkers in various bodily fluids that can be related to a person’s health status,” said Mark Brown, Executive Director of Laboratory Sciences at USANA. “This would allow our customers to see for themselves the benefit of taking USANA’s high quality products. Rather than taking a blood sample and sending it off to lab for analysis, this technology could make it possible for people to do their own analysis in the comfort of their own home. Small sample size and simplicity of use are crucial components of making this a reality, and this research is a step closer to that end.”
Learn more: PUTTING IT TO THE TEST
The Latest on: Liver cancer
- Teenager who felt like he had 'stitch' on holiday had stage 4 liver canceron May 25, 2022 at 7:43 am
Sam Amess, now 19, was diagnosed with cancer at just 11 years old and was wheelchair-bound for months when he was having chemo ...
- Singapore scientists pinpoint how non-alcoholic fatty liver disease increases risk of vascular diseaseson May 25, 2022 at 6:20 am
It is mainly characterised by having too much fat stored in liver cells and can lead to liver cirrhosis and liver cancer. It is estimated that up to 40 per cent of the population in Southeast Asian ...
- Breakthrough COVID-19 Infections More Likely in Cancer and Alzheimer’s Patients, study revealson May 25, 2022 at 6:17 am
While conducting the study, the researchers examined data on breakthrough COVID-19 cases in those with dementia because, while vaccines are effective, breakthrough infections are possible, and older ...
- What is the best cancer clinic in Mexico?on May 24, 2022 at 5:30 pm
Located in Tijuana, Immunity Therapy Center offers a great variety of alternative natural and effective cancer treatment options. Each patient has their own health and a different type of disease, and ...
- Best Anti-Cancer Foodson May 24, 2022 at 11:24 am
Most people know that there are certain steps you can take to safeguard yourself from different kinds of cancer. For example, it’s widely known that refraining from smoking cuts down your odds of ...
- Advanced Radiotherapy Offers Safe, Effective Treatment for Patients with Early-Stage Liver Cancer, Study Findson May 24, 2022 at 5:50 am
An advanced radiotherapy technique called radiation segmentectomy may be effective against very early to early-stage hepatocellular carcinoma (HCC), a type of liver cancer that cannot be treated ...
- Comment: He has liver cancer — and is waiting, waiting for treatmenton May 23, 2022 at 7:00 am
Premier John Horgan is a passionate advocate for health care, and knows cancer treatment from first-hand experience. He speaks of his gratefulness for receiving timely life-saving treatment, of the ...
- Could Aspirin Lower Your Liver Cancer Risk?on May 18, 2022 at 1:03 pm
People with hepatitis B or C are at greater risk for liver cancer, but a low-dose aspirin a day might significantly lower that risk.
- Researchers discover effective combination immunotherapy for liver canceron May 18, 2022 at 10:25 am
Researchers from the University of Missouri School of Medicine have discovered a specific combination immunotherapy that shows promise in the fight against liver cancer.
- New molecular subset of pediatric liver cancer identifiedon May 18, 2022 at 10:19 am
New research from Baylor College of Medicine and Texas Children's Cancer Center characterizes a new molecular type of high-risk pediatric liver cancer. The study, published in the Journal of ...
via Google News and Bing News